应用示例 1. 曾扬,吴小红,胡靓雅,等. 重组8 型腺相关病毒介导HBV急性感染树鼩模型建立[J].中国实验动物学报,2013,21(3):36-41. 2. 王国婧,王刚,董小岩,等.用重组8型腺相关病毒载体介导的乙型肝炎病毒持续感染小鼠模型评价核苷类似物的抗病毒效果[J].生物工程学报,2013,29(1):95-106. 3.Dan Yang, Longchao Liu, Danming Zhu, etal. A mouse model for HBV immunotolerance and immunotherapy[J]. Cellular & Molecular Immunology. 2013, 1-8.
请在“产品与服务 -> 订单管理”里拷贝订单信息,填写好内容后通过电邮发给我们。
正常为现货,订单确认后第二天发货,到货时长以物流时间为准;如大量订购,请提前与销售经理联系。
参考文献 1. 董小岩等 , 高嗜肝性 8 型重组腺相关病毒体内转导法制备乙型肝炎病毒持续感染小鼠模型 . 2010. 病毒学报 , 26(06): 425-431. 2. 郭燕菊等 , 免疫抑制剂地塞米松可明显延长乙型肝炎病毒抗原在水动力法转染 HBV 小鼠模型中的表达 . 2010. 病毒学报 ,26(01): 20-26 3. 王刚等,用 rAAV8-1.3HBV 制备两种品系小鼠乙型肝炎病毒感染模型的比较研究 . 2012. 病毒学报 , 28(05): 541-547 4. 朱欣瑶等 , 比较不同血清型 AAV 携带 HBV 基因组建立乙肝小鼠模型效果 . 2012. 生物工程学报 ,28(1):1-9. 5. 王国婧等 , 用重组 8 型腺相关病毒载体介导的乙型肝炎病毒持续感染小鼠模型评价核苷类似物的抗病毒效果 . 2013. 生物工程学报 , 29(01): 95-106. 6. 曾扬等 , 重组8型腺相关病毒介导 HBV 急性感染树鼩模型建立 . 中国实验动物学报 , 2013, 21(03): 36-41. 7. Bian Y, Zhang Z, Sun Z, Zhao J, Zhu D, Wang Y, Fu S, Guo J, Liu L, Su L, Wang FS, Fu YX, Peng H. 2017. Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice. Hepatology 66:1067-1082. 8. Dion S, Bourgine M, Godon O, Levillayer F, Michel ML. 2013. Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules. Journal of virology 87:5554-5563. 9. Kong X, Sun R, Chen Y, Wei H, Tian Z. 2014. gammadeltaT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance. J Immunol 193:1645-1653. 10. Wang Z, Zhu K, Bai W, Jia B, Hu H, Zhou D, Zhang X, Xie Y, Bourgine MM, Michel ML, Lan K, Deng Q. 2014. Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection. Journal of virology 88:3004-3015. 11. Yang D, Liu L, Zhu D, Peng H, Su L, Fu YX, Zhang L. 2014. A mouse model for HBV immunotolerance and immunotherapy. Cellular & molecular immunology 11:71-78. 12. Cheng L, Li F, Bility MT, Murphy CM, Su L. 2015. Modeling hepatitis B virus infection, immunopathology and therapy in mice. Antiviral research 121:1-8. 13. Dai K, Huang L, Chen J, Yang L, Gong Z. 2015. Amphiregulin promotes the immunosuppressive activity of intrahepatic CD4(+) regulatory T cells to impair CD8(+) T-cell immunity against hepatitis B virus infection. Immunology 144:506-517. 14. Dai K, Huang L, Sun X, Yang L, Gong Z. 2015. Hepatic CD206-positive macrophages express amphiregulin to promote the immunosuppressive activity of regulatory T cells in HBV infection. Journal of leukocyte biology 98:1071-1080. 15. Li J, Zong L, Sureau C, Barker L, Wands JR, Tong S. 2016. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor. Journal of virology 90:8302-8313. 16. Zhu D, Liu L, Yang D, Fu S, Bian Y, Sun Z, He J, Su L, Zhang L, Peng H, Fu YX. 2016. Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination. J Immunol 196:3079-3087. 17. Zhu W, Xie K, Xu Y, Wang L, Chen K, Zhang L, Fang J. 2016. CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse. Virus research 217:125-132. 18. 杨悦等,中国流行株 C 基因型 HBV 稳定复制表达小鼠模型的建立 . 2016. 解放军医学,41(10):793-797. 19. Zhao W, Zhou X, Zhao G, Lin Q, Wang X, Yu X, Wang B. 2017. Enrichment of Ly6C(hi) monocytes by multiple GM-CSF injections with HBV vaccine contributes to viral clearance in a HBV mouse model. Human vaccines & immunotherapeutics 13:2872-2882. 20. Javanbakht H, Mueller H, Walther J, Zhou X, Lopez A, Pattupara T, Blaising J, Pedersen L, Albaek N, Jackerott M, Shi T, Ploix C, Driessen W, Persson R, Ravn J, Young JAT, Ottosen S. 2018. Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo. Molecular therapy. Nucleic acids 11:441-454. 21. Liu Y, Yao W, Si L, Hou J, Wang J, Xu Z, Li W, Chen J, Li R, Li P, Bo L, Xiao X, Lan J, Xu D. 2018. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model. Antiviral research 155:39-47. 22. Tang L, Chen C, Gao X, Zhang W, Yan X, Zhou Y, Guo L, Zheng X, Wang W, Yang F, Liu G, Sun J, Hou J, Li Y. 2018. Interleukin-21 Reinvigorates the Antiviral Activity of Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Chronic HBV Infection. The Journal of infectious diseases. doi: 10.1093/infdis/jiy576.